| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| apx005m | cd40l receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] melanoma[MeSHID:D008545] Chronic Lymphocytic Leukemia[MeSHID:D015451] Malignant neoplasm of brain[MeSHID:D001932] Malignant Neoplasms[MeSHID:D009369] |
5.79 | phase 2 | unknown |
| click here to return to the previous page | ||||||||